Which paediatric asthma guidelines are the most appropriate for children and adolescents?

Symposium
Chairs: M. Pijnenburg (Rotterdam, Netherlands), E. Eber (Graz, Austria)
Aims: To describe the evidence supporting current international guidelines on treatment of children with asthma steps 1–3 and the dependence of this evidence on healthcare settings; and to describe evidence for individualised/stratified treatment in childhood asthma.

Low dose inhaled corticosteroids (ICS) and short-acting beta-agonists (SABA) or long-acting beta-agonists (LABA) need in children and adolescents with asthma steps 1 and 2: what is the evidence? L. Fleming (London, United Kingdom)
Asthma treatment in step 3: the cases for adding LABA or doubling ICS S. Turner (Aberdeen (Aberdeenshire), United Kingdom)
Comorbidities in asthma: the role of obesity in children with asthma E. Forno (Pittsburgh, United States of America)
From guidelines to personalized treatment of children with asthma J. Paton (Glasgow (Glasgow), United Kingdom)